Human Tissue Aquisition and Pathology Shared Resource
人体组织采集和病理学共享资源
基本信息
- 批准号:8733543
- 负责人:
- 金额:$ 30.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AnatomyAutopsyBiochemicalBiopsyCancer BiologyCancer CenterCancer Center Support GrantCell Adhesion MoleculesClinicalClinical PathologyClinical TrialsCollectionDiseaseDoctor of MedicineEnsureEquipmentExcisionFreezingFundingGoalsGrantHematopathologyHistologyHumanImage AnalysisLaboratory ResearchLasersMalignant NeoplasmsMicroscopyMolecularOperative Surgical ProceduresPathologyPeer ReviewProcessQuality ControlResearchResearch PersonnelResource SharingResourcesRoleServicesSpecimenTissue MicroarrayTissue SampleTissuesUnited States National Institutes of HealthWorkanticancer researchexperiencehost neoplasm interactionhuman tissueneoplasticoperationpre-clinicalprofessorresearch studytissue fixing
项目摘要
The goal of the Human Tissue Acquisition and Pathology Shared Resource (HTAP) is to provide human
tissue samples and histology services to support translafional and preclinical aspects of cancer research.
This resource has been in operation since 1993; at the last competitive renewal, this shared resource
received an "Outstanding" rating. HTAP provides researchers with access to a wide variety of human
specimens and fissues. HTAP's objectives are to collect, process, bank, and distribute remnant human
tissues (both normal and neoplastic) from routine surgical resections and autopsies for use by peer-reviewed
and funded Vanderbilt-lngram Cancer Center (VICC) investigators in basic, clinical, and translafional
research studies. This includes providing the highest quality, well-characterized fresh, frozen, and fixed
tissues suitable for a wide range of molecular, biochemical, and tissue analyses. HTAP will also assist with
the collection and banking of biopsy material for specific cancer-related clinical trials and other projects and
will perform quality control to ensure that the relevant tissue is supplied to the researcher, and that fissues
are suitable for the planned research (e.g., not necrofic or involved by unsuspected disease processes).
HTAP is well situated in regards to space and equipment. Services highly utilized by VICC investigators and
only provided by HTAP include laser capture microscopy, tissue array construction and image analysis. This
shared resource is of critical importance for the translational work of VICC invesfigators.
Mary Zutter, M.D., Professor of Pathology and Cancer Biology and Ingram Professor of Cancer
Research, became scientific director in May 2009. Dr. Zutter directs a research laboratory that focuses on
the role of cell adhesion molecules in host-tumor interactions. She has been funded continuously by the NIH
for the past 17 years and is currently supported by three R01 grants from the NCI. In addition, she is board
certified in Anatomic and Clinical Pathology and directs the Division of Hematopathology. She is assisted by
a staff with decades of experience and by the Informafics Shared Resource, under the direction of Dan
Masys, M.D.
人体组织采集和病理学共享资源 (HTAP) 的目标是为人类提供
组织样本和组织学服务,支持癌症研究的转化和临床前方面。
该资源自 1993 年开始运行;在上次竞争性更新时,此共享资源
获得“优秀”评级。 HTAP 为研究人员提供了接触各种人类
标本和组织。 HTAP 的目标是收集、处理、储存和分发剩余人类
来自常规手术切除和尸检的组织(正常和肿瘤)供同行评审使用
并资助范德比尔特-英格拉姆癌症中心 (VICC) 的基础、临床和转化研究人员
研究。这包括提供最高品质、特性良好的新鲜、冷冻和固定产品
适用于广泛的分子、生化和组织分析的组织。 HTAP 还将协助
为特定癌症相关临床试验和其他项目收集和储存活检材料,以及
将进行质量控制,以确保向研究人员提供相关组织,并且组织
适合计划的研究(例如,不坏死或涉及意外的疾病过程)。
HTAP 在空间和设备方面都处于有利位置。 VICC 调查人员高度利用的服务
仅由 HTAP 提供的包括激光捕获显微镜、组织阵列构建和图像分析。这
共享资源对于 VICC 调查人员的转化工作至关重要。
Mary Zutter,医学博士,病理学和癌症生物学教授兼英格拉姆癌症教授
研究,于 2009 年 5 月成为科学总监。Zutter 博士领导一个研究实验室,专注于
细胞粘附分子在宿主-肿瘤相互作用中的作用。她一直受到 NIH 的资助
过去 17 年,目前得到 NCI 的三项 R01 资助的支持。此外,她还是董事会成员
获得解剖学和临床病理学认证,并领导血液病理学部门。她的协助者是
拥有数十年经验的员工,在 Dan 的指导下,通过信息学共享资源
马西斯医学博士
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY M. ZUTTER其他文献
MARY M. ZUTTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY M. ZUTTER', 18)}}的其他基金
Human Tissue Aquisition and Pathology Shared Resource
人体组织采集和病理学共享资源
- 批准号:
8180573 - 财政年份:2010
- 资助金额:
$ 30.11万 - 项目类别:
Unexpected Roles for the alpha2beta1 Integrin
α2β1 整合素的意想不到的作用
- 批准号:
6959343 - 财政年份:2005
- 资助金额:
$ 30.11万 - 项目类别:
相似海外基金
Molecular Phenotyping of Cortical Cell Types in ALS-Related Neurodegeneration
ALS 相关神经变性中皮质细胞类型的分子表型
- 批准号:
10745149 - 财政年份:2023
- 资助金额:
$ 30.11万 - 项目类别:
The Impact of Normative Aging and Alzheimers Disease on Fear based Disorders and Amygdala Dysfunction
正常衰老和阿尔茨海默病对恐惧障碍和杏仁核功能障碍的影响
- 批准号:
10889548 - 财政年份:2023
- 资助金额:
$ 30.11万 - 项目类别:
The role of PPARγ in astrocyte pathobiology after exposure to repetitive mild traumatic brain injury
PPARγ 在重复性轻度脑外伤后星形胶质细胞病理学中的作用
- 批准号:
10739968 - 财政年份:2023
- 资助金额:
$ 30.11万 - 项目类别:
5HT3 receptors and blood-brain barrier dysfunction in ADRD
ADRD 中的 5HT3 受体和血脑屏障功能障碍
- 批准号:
10575480 - 财政年份:2023
- 资助金额:
$ 30.11万 - 项目类别:
The interplay between Tau and ncRNAs – genomic and epigenomic clues to early AD pathogenesis
Tau 和 ncRNA 之间的相互作用 — 早期 AD 发病机制的基因组和表观基因组线索
- 批准号:
10634661 - 财政年份:2022
- 资助金额:
$ 30.11万 - 项目类别: